Synthetic Cannabinoids Market

Q: What will be the CAGR of the global synthetic cannabinoids industry during the forecast period?

The CAGR is anticipated to be 17.6% from 2025 to 2035 Read More

Synthetic Cannabinoids Market (Product Type: Full-Spectrum Cannabinoids, Broad-Spectrum Cannabinoids and Isolate Cannabinoids; Formulation: Oil, Capsules, Edibles, Vapes and Others; and Indication: Pain Management, Nausea/Vomiting, Neurological Disorder Management, Seizures and Others) – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025-2035

Analysts’ Viewpoint regarding Synthetic Cannabinoids Market

The synthetic cannabinoids market is undergoing acceleration towing to the increased use of cannabinoids-based drugs in various therapies. Synthetic cannabinoids like nabilone and dronabinol are the primary drug choices for treating chemotherapy-induced nausea and vomiting, as along with weight loss in AIDS patients.

Synthetic Cannabinoids Market Outlook 2035

The global synthetic cannabinoids industry was valued at US$ 3.2 Bn in 2024
The global synthetic cannabinoids market is projected to grow at a CAGR of 17.6% from 2025 to 2035 and cross US$ 19.3 Bn by the end of 2035

Synthetic Cannabinoids Market By Revenue

Demand for these substances is rising owing to rising awareness of healthcare potentials of synthetic cannabinoids and the supportive regulatory environment provided therein. Furthermore, the growing prevalence of chronic pain, cancer, and neurodegenerative diseases is leading to an increase in the number of cannabinoids prescriptions, which, in turn, contributes to the growth of the market.

Ongoing pharmaceutical research and drug discovery processes comprise another major factor driving the synthetic cannabinoids market. Numerous biopharmaceutical companies and research facilities are involved in manufacturing synthetic cannabinoids for epilepsy, multiple sclerosis, and mental disorders. Their ability of controlled dosing and standardized formulation does make them more reliable than cannabinoids derived from plants, thereby lowering the risk of contamination and dose variability.

The rising popularity of cannabis-derived products and the changing regulations and legalizations in different places globally do offer a favorable environment for synthetic cannabinoids. Altering consumer knowledge and perceptions of cannabis are also contributing to the growth of synthetic cannabinoids market.

Recent trends in the synthetic cannabinoids market are indicative of a vibrant and changing market. The most significant of these are the increasing demand for products that have specifically designed therapeutic effects, e.g., for pain, anxiety, and sleeping disorders. As a result, the industry has come up with new niche medicines and delivery methods, e.g., edibles, oils, and vaporizers, which cater to a wide variety of consumer preference.

Another trend is the development of research-based products, where companies are investing in clinical trials to demonstrate the safety and efficacy of synthetic cannabinoids to gain consumer trust. The market is also witnessing the wellness industry taking an interest in it, wherein consumers are looking for natural ways of health and wellness.

The synthetic cannabinoids market is acutely competitive; with companies operating in this space undertaking numerous initiatives to propel innovation and expand their product offerings. Firms are focusing on research and development activities to synthesize advanced formulations that elevate bioavailability and efficacy. Additionally, some firms are investing in sustainable sourcing and manufacturing practices for appealing to environmentally-conscious consumers.

Synthetic Cannabinoids Market Introduction

Synthetic cannabinoids comprise a wide category of man-made chemical compounds that are designed for mimicking the effects of naturally occurring cannabinoids that are found in cannabis plants such as tetrahydrocannabinol (THC) and cannabidiol (CBD). Unlike naturally occurring cannabinoids, the substances are often formulated for binding more effectively to cannabinoid receptors in the brain, thereby resulting in potent psychoactive effects.

Chemically, the synthetic cannabinoids form a range of families and frameworks including naphthoylindoles, cyclohexylphenols, phenylacetylindoles, and indazole carboxamides. Despite their chemical heterogenity, the compounds are typically lipid-soluble, volatile, and non-polar, all sharing a critical side-chain structure necessary for their interaction with cannabinoid receptors.

Synthetic cannabinoids are generally pharmacologically designed to be CB1 and CB2 agonists, binding more potently than THC itself. The erratic strength and considerable structural variations have led synthetic cannabinoids to become a prime area of concern for regulatory and public health agencies globally. Their heterogeneity and the rapid development of new emerging variants cause massive challenges for clinicians and policymakers to detect, control, and contain health risks associated with them.

Attribute	Detail
Synthetic Cannabinoids Market Drivers	Rising Demand for Recreational and Alternative Drugs Increasing Prevalence of Neurological Disorder

Rising Demand for Recreational and Alternative Drugs is Skyrocketing the Synthetic Cannabinoids Market Share

Synthetic cannabinoid industry is propelled by increasing popularity for recreational and alternative drugs. Individuals predominantly look for legal or readily available alternatives to natural cannabis, especially in regions where use of cannabis is banned. Synthetic cannabinoids have turned out to be alternatives as they are easily available and potent in terms of psychoactive impact. This demand is establishing a consistent consumer base, even though there are increasing concerns regarding the legality and safety of such products.

They are available in different types including smoking blends, vaping liquids, and edibles. Such a way of consumption allows the customers to have a greater choice and thus attracts more customers.

Furthermore, synthetic cannabinoids differ from conventional cannabis in terms of unique psychoactive effects. Continuous adjustments of chemical structures give the manufacturers the opportunity to create numerous variants, thus, keeping the consumer's interest. Besides, the view of synthetic cannabinoids as new and innovative alternatives to the market helps their presence despite the legal challenges.

Increasing Prevalence of Neurological Disorders Fostering Synthetic Cannabinoids Market Share

The increase in number of neurological disorders has become one of the key factors contributing towards the growth of synthetic cannabinoids industry. The main reason for this is the growing recognition of the medical use of synthetic cannabinoids for various neurological diseases like pain relief, epilepsy, MS, Parkinson's, Alzheimer's, and various other cognitive impairments.

Cannabinoids of both - natural and synthetic origin have demonstrated the capability of protecting the nervous system, and it may be the future of a successful treatment for neurodegenerative diseases. Synthetic cannabinoids that are synthe`sized to duplicate natural cannabinoids (such as THC and CBD) can provide healthcare benefits of cannabis without side-effects or legal issues related to the plant.

MS is generally accompanied by extremely painful muscle spasticity, which can be controlled by the use of synthetic cannabinoids. Cannabinoids are found to be effective in muscle spasm relief, movement facilitation, and chronic pain management in conditions such as MS and spinal cord injury. For instance, Sativex, a medicine created by combining THC with CBD, has been approved for use in the treatment of MS patients in various locations worldwide to alleviate the spasticity treatment.

Additionally, synthetic cannabinoids have also been investigated for their ability to treat epilepsy, especially in refractory cases where conventional antiepileptic drugs fail. Research shows that cannabinoids such as Epidiolex are useful in the reduction of seizure frequency in certain types of epilepsy like Dravet syndrome.

The ongoing clinical trials further contribute in maintaining the target market’s position in this field. The scientists are investigating the ability of synthetic cannabinoids to slow down the disease, improve brain functions, and control the behavioral symptoms in the patients suffering from neurodegenerative disorders. The positive outcomes of the trials not only extend the therapeutic applications but also encourage the authorities, thereby making it easier for the patients to access these compounds. This scientific confirmation is crucial for their acceptance under neurology-focused therapy.

The escalating global scenario of neurological disorders is the main reason for the continuous requirement of new and effective therapeutic options. The healthcare systems are giving priority to advanced treatment modalities as the aging population, and the number of diagnoses continue to rise. The R&D-supported synthetic cannabinoids are turning to be the effective solutions to these problems. Their inclusion in the neurology care pathways is a clear indication that the increased frequency of such disorders is the main reason for the growth and acceptance of synthetic cannabinoids in contemporary medicine.

Pain Management Leading Global Synthetic Cannabinoids Market

Synthetic Cannabinoids Market By Indication

The pain management segment leads since the chemicals target the endocannabinoid system that governs pain perception. Synthetic cannabinoids such as dronabinol and nabilone are prescribed to patients suffering from neuropathic pain, chronic pain, and cancer pain. Additionally, their controlled dose and pharmaceutical grade do guarantee predictability.

In addition, the growing incidences of cancer, arthritis, and multiple sclerosis continues to fuel demand for effective pain management products. Synthetic cannabinoids do provide more predictable and safer alternatives to opioids, thereby reducing risk of dependency while providing therapeutic benefit and making them the choice of preference in this category.

Regional Outlook of Synthetic Cannabinoids Market

Synthetic Cannabinoids Market By Region

Attribute	Detail
Leading Region	North America

As per the latest market analysis, North America dominated in 2024. This is attributed to the region's strong pharmaceutical industry, its advanced research base, and the high prevalence of cancer, chronic pain, and neurological disorders. The region benefits from a well-established regulatory system that is conducive to the approval and commercialization of synthetic cannabinoid-derived medicines such as dronabinol and nabilone.

Analysis of Key Players in Synthetic Cannabinoids Market

The companies operating in the synthetic cannabinoids market are expediting clinical trials, developing new products, and expanding the therapeutic uses of these products. The firms are actively collaborating with research institutions and universities and investing in biosynthetic manufacturing technology.

Noramco, Botanix SB Inc., CV Sciences, Inc., Jazz Pharmaceuticals plc, BIOVECTRA, BayMedica, LLC, Kannalife Sciences, Inc., Curaleaf Clinic (Sapphire Medical Clinics Ltd), Cannabix Technologies Inc., Skye Bioscience, Aurora Behavioral Health System, Tilray, Green Thumb Industries (GTI), Trulieve, and Terrascend are some of the leading players operating in the global synthetic cannabinoids market.

Each of these players has been profiled in the synthetic cannabinoids market research report based on parameters such as company overview, financial overview, business strategies, product portfolio, business segments, and recent developments.

Key Developments in Synthetic Cannabinoids Market

In August 2025, CV Sciences, Inc. introduced Ignite, formulas specifically designed for men 35+ seeking natural support for energy, recovery, and mental focus. Ignite has combined clinically accepted botanicals with full spectrum CBD to assist men in performing their best in all areas of life.
In May 2021, Jazz Pharmaceuticals announced its acquisition of GW Pharmaceuticals plc, a pioneer in the science, development, and commercialization of prescription cannabinoid pharmaceuticals. The acquisition brought GW into their commercial portfolio and pipeline of innovative medicines with supportive therapies for their business, including Epidiolex.

Synthetic Cannabinoids Market Snapshot

Attribute	Detail
Size in 2024	US$ 3.2 Bn
Forecast Value in 2035	US$ 19.3 Bn
CAGR	17.6%
Forecast Period	2025-2035
Historical Data Available for	2020-2023
Quantitative Units	US$ Bn
Synthetic Cannabinoids Market Analysis	It includes segment analysis as well as regional level analysis. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, value chain analysis, and key trend analysis.
Competition Landscape	Competition Matrix Company profiles section includes overview, product portfolio, sales footprint, key subsidiaries or distributors, strategy & recent developments, and key financials
Format	Electronic (PDF) + Excel
Segmentation	Product Type Full-Spectrum Cannabinoids Broad-Spectrum Cannabinoids Isolate Cannabinoids Formulation Oil Capsules Edibles Vapes Others (Topical, etc.) Indication Pain Management Nausea/Vomiting Neurological Disorder Management Seizures Others (Anxiety, etc.) Distribution Channel Hospital Pharmacies Retail Pharmacies Online Pharmacies
Regions Covered	North America Europe Asia Pacific Latin America Middle East & Africa
Countries Covered	U.S. Canada Germany U.K. France Italy Spain The Netherlands China Australia India Japan South Korea ASEAN Brazil Mexico Argentina GCC Countries South Africa
Companies Profiled	Noramco Botanix SB Inc. CV Sciences, Inc. Jazz Pharmaceuticals plc BIOVECTRA BayMedica, LLC Kannalife Sciences, Inc. Curaleaf Clinic (Sapphire Medical Clinics Ltd) Cannabix Technologies Inc. Skye Bioscience Aurora Behavioral Health System Tilray Green Thumb Industries (GTI) Trulieve Terrascend
Customization Scope	Available upon request
Pricing	Available upon request

Frequently Asked Questions

How big was the global synthetic cannabinoids market in 2024?

The global synthetic cannabinoids market was valued at US$ 3.2 Bn in 2024

How big will the global synthetic cannabinoids industry be in 2035?

The global synthetic cannabinoids industry is projected to reach more than US$ 19.3 Bn by the end of 2035

What are the factors driving the synthetic cannabinoids market?

The rising demand for recreational and alternative drugs, growing pharmaceutical and biotechnology investments, rising prevalence of neurological disorders, rising consumer awareness, and the expanding medical and therapeutic applications of synthetic cannabinoids are some of the factors driving the expansion of synthetic cannabinoids market.

What will be the CAGR of the global synthetic cannabinoids industry during the forecast period?

The CAGR is anticipated to be 17.6% from 2025 to 2035

Who are the prominent players in the global synthetic cannabinoids market?

Noramco, Botanix SB Inc., CV Sciences, Inc., Jazz Pharmaceuticals plc, BIOVECTRA, BayMedica, LLC, Kannalife Sciences, Inc., Curaleaf Clinic (Sapphire Medical Clinics Ltd), Cannabix Technologies Inc.., Skye Bioscience, Aurora Behavioral Health System, Tilray, Green Thumb Industries (GTI), Trulieve, and Terrascend

Preface
- Market Definition and Scope
- Market Segmentation
- Key Research Objectives
- Research Highlights
Assumptions and Research Methodology
Executive Summary: Global Synthetic Cannabinoids Market
Market Overview
- Introduction
  - Segment Definition
- Overview
- Market Dynamics
  - Drivers
  - Restraints
  - Opportunities
- Global Synthetic Cannabinoids Market Analysis and Forecast, 2020 - 2035
  - Market Revenue Projections (US$ Bn)
Key Insights
- Distributor Landscape
- Recent Advancements in Synthetic Cannabinoids Industry
- Pricing Trends of Synthetic Cannabinoids
- Regulatory Scenario across Key Regions / Countries
- PORTER’s Five Forces Analysis
- PESTLE Analysis
- Go-to-Market Strategy for New Market Entrants
- Key Purchase Metrics for End-users
- Key Industry Events (Partnership, Collaborations, Product approvals, merger & acquisitions)
- Benchmarking of the Products Offered by the Leading Competitors
Global Synthetic Cannabinoids Market Analysis and Forecast, by Product Type
- Introduction & Definition
- Key Findings/Developments
- Market Value Forecast, by Product Type, 2020 - 2035
  - Full-Spectrum Cannabinoids
  - Broad-Spectrum Cannabinoids
  - Isolate Cannabinoids
- Market Attractiveness Analysis, by Product Type
Global Synthetic Cannabinoids Market Analysis and Forecast, by Formulation
- Introduction & Definition
- Key Findings/Developments
- Market Value Forecast, by Formulation, 2020 - 2035
  - Oil
  - Capsules
  - Edibles
  - Vapes
  - Others
- Market Attractiveness Analysis, by Formulation
Global Synthetic Cannabinoids Market Analysis and Forecast, by Indication
- Introduction & Definition
- Key Findings/Developments
- Market Value Forecast, by Indication, 2020 - 2035
  - Pain Management
  - Nausea/Vomiting
  - Neurological Disorder Management
  - Seizures
  - Others
- Market Attractiveness Analysis, by Indication
Global Synthetic Cannabinoids Market Analysis and Forecast, by Distribution Channel
- Introduction & Definition
- Key Findings/Developments
- Market Value Forecast, by Distribution Channel, 2020 - 2035
  - Hospital Pharmacies
  - Retail Pharmacies
  - Online Pharmacies
- Market Attractiveness Analysis, by Distribution Channel
Global Synthetic Cannabinoids Market Analysis and Forecast, by Region
- Key Findings
- Market Value Forecast, by Region, 2020 - 2035
  - North America
  - Europe
  - Asia Pacific
  - Latin America
  - Middle East & Africa
- Market Attractiveness By Region
North America Synthetic Cannabinoids Market Analysis and Forecast
- Introduction
  - Key Findings
- Market Value Forecast, by Product Type, 2020 - 2035
  - Full-Spectrum Cannabinoids
  - Broad-Spectrum Cannabinoids
  - Isolate Cannabinoids
- Market Value Forecast, by Formulation, 2020 - 2035
  - Oil
  - Capsules
  - Edibles
  - Vapes
  - Others
- Market Value Forecast, by Indication, 2020 - 2035
  - Pain Management
  - Nausea/Vomiting
  - Neurological Disorder Management
  - Seizures
  - Others
- Market Value Forecast, by Distribution Channel, 2020 - 2035
  - Hospital Pharmacies
  - Retail Pharmacies
  - Online Pharmacies
- Market Value Forecast, by Country, 2020 - 2035
  - U.S.
  - Canada
- Market Attractiveness Analysis
  - By Product Type
  - By Formulation
  - By Indication
  - By Distribution Channel
  - By Country
Europe Synthetic Cannabinoids Market Analysis and Forecast
- Introduction
  - Key Findings
- Market Value Forecast, by Product Type, 2020 - 2035
  - Full-Spectrum Cannabinoids
  - Broad-Spectrum Cannabinoids
  - Isolate Cannabinoids
- Market Value Forecast, by Formulation, 2020 - 2035
  - Oil
  - Capsules
  - Edibles
  - Vapes
  - Others
- Market Value Forecast, by Indication, 2020 - 2035
  - Pain Management
  - Nausea/Vomiting
  - Neurological Disorder Management
  - Seizures
  - Others
- Market Value Forecast, by Distribution Channel, 2020 - 2035
  - Hospital Pharmacies
  - Retail Pharmacies
  - Online Pharmacies
- Market Value Forecast, by Country/Sub-region, 2020 - 2035
  - UK
  - Germany
  - France
  - Italy
  - Spain
  - The Netherlands
  - Rest of Europe
- Market Attractiveness Analysis
  - By Product Type
  - By Formulation
  - By Indication
  - By Distribution Channel
  - By Country/Sub-region
Asia Pacific Synthetic Cannabinoids Market Analysis and Forecast
- Introduction
  - Key Findings
- Market Value Forecast, by Product Type, 2020 - 2035
  - Full-Spectrum Cannabinoids
  - Broad-Spectrum Cannabinoids
  - Isolate Cannabinoids
- Market Value Forecast, by Formulation, 2020 - 2035
  - Oil
  - Capsules
  - Edibles
  - Vapes
  - Others
- Market Value Forecast, by Indication, 2020 - 2035
  - Pain Management
  - Nausea/Vomiting
  - Neurological Disorder Management
  - Seizures
  - Others
- Market Value Forecast, by Distribution Channel, 2020 - 2035
  - Hospital Pharmacies
  - Retail Pharmacies
  - Online Pharmacies
- Market Value Forecast, by Country/Sub-region, 2020 - 2035
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
- Market Attractiveness Analysis
  - By Product Type
  - By Formulation
  - By Indication
  - By Distribution Channel
  - By Country/Sub-region
Latin America Synthetic Cannabinoids Market Analysis and Forecast
- Introduction
  - Key Findings
- Market Value Forecast, by Product Type, 2020 - 2035
  - Full-Spectrum Cannabinoids
  - Broad-Spectrum Cannabinoids
  - Isolate Cannabinoids
- Market Value Forecast, by Formulation, 2020 - 2035
  - Oil
  - Capsules
  - Edibles
  - Vapes
  - Others
- Market Value Forecast, by Indication, 2020 - 2035
  - Pain Management
  - Nausea/Vomiting
  - Neurological Disorder Management
  - Seizures
  - Others
- Market Value Forecast, by Distribution Channel, 2020 - 2035
  - Hospital Pharmacies
  - Retail Pharmacies
  - Online Pharmacies
- Market Value Forecast, by Country/Sub-region, 2020 - 2035
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
- Market Attractiveness Analysis
  - By Product Type
  - By Formulation
  - By Indication
  - By Distribution Channel
  - By Country/Sub-region
Middle East & Africa Synthetic Cannabinoids Market Analysis and Forecast
- Introduction
  - Key Findings
- Market Value Forecast, by Product Type, 2020 - 2035
  - Full-Spectrum Cannabinoids
  - Broad-Spectrum Cannabinoids
  - Isolate Cannabinoids
- Market Value Forecast, by Formulation, 2020 - 2035
  - Oil
  - Capsules
  - Edibles
  - Vapes
  - Others
- Market Value Forecast, by Indication, 2020 - 2035
  - Pain Management
  - Nausea/Vomiting
  - Neurological Disorder Management
  - Seizures
  - Others
- Market Value Forecast, by Distribution Channel, 2020 - 2035
  - Hospital Pharmacies
  - Retail Pharmacies
  - Online Pharmacies
- Market Value Forecast, by Country/Sub-region, 2020 - 2035
  - GCC Countries
  - South Africa
  - Rest of Middle East & Africa
- Market Attractiveness Analysis
  - By Product Type
  - By Formulation
  - By Indication
  - By Distribution Channel
  - By Country/Sub-region
Competition Landscape
- Market Player - Competition Matrix (By Tier and Size of Companies)
- Market Share Analysis, by Company (2024)
- Company Profiles
  - Noramco
    - Company Overview
    - Financial Overview
    - Financial Overview
    - Business Strategies
    - Recent Developments
  - Botanix SB Inc.
    - Company Overview
    - Financial Overview
    - Financial Overview
    - Business Strategies
    - Recent Developments
  - CV Sciences, Inc.
    - Company Overview
    - Financial Overview
    - Financial Overview
    - Business Strategies
    - Recent Developments
  - Jazz Pharmaceuticals plc
    - Company Overview
    - Financial Overview
    - Financial Overview
    - Business Strategies
    - Recent Developments
  - BIOVECTRA
    - Company Overview
    - Financial Overview
    - Financial Overview
    - Business Strategies
    - Recent Developments
  - BayMedica, LLC
    - Company Overview
    - Financial Overview
    - Financial Overview
    - Business Strategies
    - Recent Developments
  - Kannalife Sciences, Inc.
    - Company Overview
    - Financial Overview
    - Financial Overview
    - Business Strategies
    - Recent Developments
  - Curaleaf Clinic (Sapphire Medical Clinics Ltd)
    - Company Overview
    - Financial Overview
    - Financial Overview
    - Business Strategies
    - Recent Developments
  - Cannabix Technologies Inc.
    - Company Overview
    - Financial Overview
    - Financial Overview
    - Business Strategies
    - Recent Developments
  - Skye Bioscience
    - Company Overview
    - Financial Overview
    - Financial Overview
    - Business Strategies
    - Recent Developments
  - Aurora Behavioral Health System
    - Company Overview
    - Financial Overview
    - Financial Overview
    - Business Strategies
    - Recent Developments
  - Tilray
    - Company Overview
    - Financial Overview
    - Financial Overview
    - Business Strategies
    - Recent Developments
  - Green Thumb Industries (GTI)
    - Company Overview
    - Financial Overview
    - Financial Overview
    - Business Strategies
    - Recent Developments
  - Trulieve
    - Company Overview
    - Financial Overview
    - Financial Overview
    - Business Strategies
    - Recent Developments
  - TerrAscend
    - Company Overview
    - Financial Overview
    - Financial Overview
    - Business Strategies
    - Recent Developments

List of Tables

Table 01: Global Synthetic Cannabinoids Market Value (US$ Bn) Forecast, By Product Type, 2020 to 2035
Table 02: Global Synthetic Cannabinoids Market Value (US$ Bn) Forecast, By Formulation, 2020 to 2035
Table 03: Global Synthetic Cannabinoids Market Value (US$ Bn) Forecast, By Indication, 2020 to 2035
Table 04: Global Synthetic Cannabinoids Market Value (US$ Bn) Forecast, By Distribution Channel, 2020 to 2035
Table 05: Global Synthetic Cannabinoids Market Value (US$ Bn) Forecast, By Region, 2020 to 2035
Table 06: North America Synthetic Cannabinoids Market Value (US$ Bn) Forecast, by Country, 2020-2035
Table 07: North America Synthetic Cannabinoids Market Value (US$ Bn) Forecast, By Product Type, 2020 to 2035
Table 08: North America Synthetic Cannabinoids Market Value (US$ Bn) Forecast, By Formulation, 2020 to 2035
Table 09: North America Synthetic Cannabinoids Market Value (US$ Bn) Forecast, By Indication, 2020 to 2035
Table 10: North America Synthetic Cannabinoids Market Value (US$ Bn) Forecast, By Distribution Channel, 2020 to 2035
Table 11: Europe Synthetic Cannabinoids Market Value (US$ Bn) Forecast, by Country/Sub-region, 2020-2035
Table 12: Europe Synthetic Cannabinoids Market Value (US$ Bn) Forecast, By Product Type, 2020 to 2035
Table 13: Europe Synthetic Cannabinoids Market Value (US$ Bn) Forecast, By Formulation, 2020 to 2035
Table 14: Europe Synthetic Cannabinoids Market Value (US$ Bn) Forecast, By Indication, 2020 to 2035
Table 15: Europe Synthetic Cannabinoids Market Value (US$ Bn) Forecast, By Distribution Channel, 2020 to 2035
Table 16: Asia Pacific Synthetic Cannabinoids Market Value (US$ Bn) Forecast, by Country/Sub-region, 2020-2035
Table 17: Asia Pacific Synthetic Cannabinoids Market Value (US$ Bn) Forecast, By Product Type, 2020 to 2035
Table 18: Asia Pacific Synthetic Cannabinoids Market Value (US$ Bn) Forecast, By Formulation, 2020 to 2035
Table 19: Asia Pacific Synthetic Cannabinoids Market Value (US$ Bn) Forecast, By Indication, 2020 to 2035
Table 20: Asia Pacific Synthetic Cannabinoids Market Value (US$ Bn) Forecast, By Distribution Channel, 2020 to 2035
Table 21: Latin America Synthetic Cannabinoids Market Value (US$ Bn) Forecast, by Country/Sub-region, 2020-2035
Table 22: Latin America Synthetic Cannabinoids Market Value (US$ Bn) Forecast, By Product Type, 2020 to 2035
Table 23: Latin America Synthetic Cannabinoids Market Value (US$ Bn) Forecast, By Formulation, 2020 to 2035
Table 24: Latin America Synthetic Cannabinoids Market Value (US$ Bn) Forecast, By Indication, 2020 to 2035
Table 25: Latin America Synthetic Cannabinoids Market Value (US$ Bn) Forecast, By Distribution Channel, 2020 to 2035
Table 26: Middle East & Africa Synthetic Cannabinoids Market Value (US$ Bn) Forecast, by Country/Sub-region, 2020-2035
Table 27: Middle East & Africa Synthetic Cannabinoids Market Value (US$ Bn) Forecast, By Product Type, 2020 to 2035
Table 28: Middle East & Africa Synthetic Cannabinoids Market Value (US$ Bn) Forecast, By Formulation, 2020 to 2035
Table 29: Middle East & Africa Synthetic Cannabinoids Market Value (US$ Bn) Forecast, By Indication, 2020 to 2035
Table 30: Middle East & Africa Synthetic Cannabinoids Market Value (US$ Bn) Forecast, By Distribution Channel, 2020 to 2035

List of Figures

Figure 01: Global Synthetic Cannabinoids Market Value Share Analysis, By Product Type, 2024 and 2035
Figure 02: Global Synthetic Cannabinoids Market Attractiveness Analysis, By Product Type, 2025 to 2035
Figure 03: Global Synthetic Cannabinoids Market Revenue (US$ Bn), by Full-Spectrum Cannabinoids, 2020 to 2035
Figure 04: Global Synthetic Cannabinoids Market Revenue (US$ Bn), by Broad-Spectrum Cannabinoids, 2020 to 2035
Figure 05: Global Synthetic Cannabinoids Market Revenue (US$ Bn), by Isolate Cannabinoids, 2020 to 2035
Figure 06: Global Synthetic Cannabinoids Market Value Share Analysis, By Formulation, 2024 and 2035
Figure 07: Global Synthetic Cannabinoids Market Attractiveness Analysis, By Formulation, 2025 to 2035
Figure 08: Global Synthetic Cannabinoids Market Revenue (US$ Bn), by Oil, 2020 to 2035
Figure 09: Global Synthetic Cannabinoids Market Revenue (US$ Bn), by Capsules, 2020 to 2035
Figure 10: Global Synthetic Cannabinoids Market Revenue (US$ Bn), by Edibles, 2020 to 2035
Figure 11: Global Synthetic Cannabinoids Market Revenue (US$ Bn), by Vapes, 2020 to 2035
Figure 12: Global Synthetic Cannabinoids Market Revenue (US$ Bn), by Others, 2020 to 2035
Figure 13: Global Synthetic Cannabinoids Market Value Share Analysis, By Indication, 2024 and 2035
Figure 14: Global Synthetic Cannabinoids Market Attractiveness Analysis, By Indication, 2025 to 2035
Figure 15: Global Synthetic Cannabinoids Market Revenue (US$ Bn), by Pain Management, 2020 to 2035
Figure 16: Global Synthetic Cannabinoids Market Revenue (US$ Bn), by Nausea/Vomiting, 2020 to 2035
Figure 17: Global Synthetic Cannabinoids Market Revenue (US$ Bn), by Neurological Disorder Management, 2020 to 2035
Figure 18: Global Synthetic Cannabinoids Market Revenue (US$ Bn), by Seizures, 2020 to 2035
Figure 19: Global Synthetic Cannabinoids Market Revenue (US$ Bn), by Others, 2020 to 2035
Figure 20: Global Synthetic Cannabinoids Market Value Share Analysis, By Distribution Channel, 2024 and 2035
Figure 21: Global Synthetic Cannabinoids Market Attractiveness Analysis, By Distribution Channel, 2025 to 2035
Figure 22: Global Synthetic Cannabinoids Market Revenue (US$ Bn), by Hospital Pharmacies, 2020 to 2035
Figure 23: Global Synthetic Cannabinoids Market Revenue (US$ Bn), by Retail Pharmacies, 2020 to 2035
Figure 24: Global Synthetic Cannabinoids Market Revenue (US$ Bn), by Online Pharmacies, 2020 to 2035
Figure 25: Global Synthetic Cannabinoids Market Value Share Analysis, By Region, 2024 and 2035
Figure 26: Global Synthetic Cannabinoids Market Attractiveness Analysis, By Region, 2025 to 2035
Figure 27: North America Synthetic Cannabinoids Market Value (US$ Bn) Forecast, 2020 to 2035
Figure 28: North America Synthetic Cannabinoids Market Value Share Analysis, by Country, 2024 and 2035
Figure 29: North America Synthetic Cannabinoids Market Attractiveness Analysis, by Country, 2025 to 2035
Figure 30: North America Synthetic Cannabinoids Market Value Share Analysis, By Product Type, 2024 and 2035
Figure 31: North America Synthetic Cannabinoids Market Attractiveness Analysis, By Product Type, 2025 to 2035
Figure 32: North America Synthetic Cannabinoids Market Value Share Analysis, By Formulation, 2024 and 2035
Figure 33: North America Synthetic Cannabinoids Market Attractiveness Analysis, By Formulation, 2025 to 2035
Figure 34: North America Synthetic Cannabinoids Market Value Share Analysis, By Indication, 2024 and 2035
Figure 35: North America Synthetic Cannabinoids Market Attractiveness Analysis, By Indication, 2025 to 2035
Figure 36: North America Synthetic Cannabinoids Market Value Share Analysis, By Distribution Channel, 2024 and 2035
Figure 37: North America Synthetic Cannabinoids Market Attractiveness Analysis, By Distribution Channel, 2025 to 2035
Figure 38: Europe Synthetic Cannabinoids Market Value (US$ Bn) Forecast, 2020 to 2035
Figure 39: Europe Synthetic Cannabinoids Market Value Share Analysis, by Country/Sub-region, 2024 and 2035
Figure 40: Europe Synthetic Cannabinoids Market Attractiveness Analysis, by Country/Sub-region, 2025 to 2035
Figure 41: Europe Synthetic Cannabinoids Market Value Share Analysis, By Product Type, 2024 and 2035
Figure 42: Europe Synthetic Cannabinoids Market Attractiveness Analysis, By Product Type, 2025 to 2035
Figure 43: Europe Synthetic Cannabinoids Market Value Share Analysis, By Formulation, 2024 and 2035
Figure 44: Europe Synthetic Cannabinoids Market Attractiveness Analysis, By Formulation, 2025 to 2035
Figure 45: Europe Synthetic Cannabinoids Market Value Share Analysis, By Indication, 2024 and 2035
Figure 46: Europe Synthetic Cannabinoids Market Attractiveness Analysis, By Indication, 2025 to 2035
Figure 47: Europe Synthetic Cannabinoids Market Value Share Analysis, By Distribution Channel, 2024 and 2035
Figure 48: Europe Synthetic Cannabinoids Market Attractiveness Analysis, By Distribution Channel, 2025 to 2035
Figure 49: Asia Pacific Synthetic Cannabinoids Market Value (US$ Bn) Forecast, 2020 to 2035
Figure 50: Asia Pacific Synthetic Cannabinoids Market Value Share Analysis, by Country/Sub-region, 2024 and 2035
Figure 51: Asia Pacific Synthetic Cannabinoids Market Attractiveness Analysis, by Country/Sub-region, 2025 to 2035
Figure 52: Asia Pacific Synthetic Cannabinoids Market Value Share Analysis, By Product Type, 2024 and 2035
Figure 53: Asia Pacific Synthetic Cannabinoids Market Attractiveness Analysis, By Product Type, 2025 to 2035
Figure 54: Asia Pacific Synthetic Cannabinoids Market Value Share Analysis, By Formulation, 2024 and 2035
Figure 55: Asia Pacific Synthetic Cannabinoids Market Attractiveness Analysis, By Formulation, 2025 to 2035
Figure 56: Asia Pacific Synthetic Cannabinoids Market Value Share Analysis, By Indication, 2024 and 2035
Figure 57: Asia Pacific Synthetic Cannabinoids Market Attractiveness Analysis, By Indication, 2025 to 2035
Figure 58: Asia Pacific Synthetic Cannabinoids Market Value Share Analysis, By Distribution Channel, 2024 and 2035
Figure 59: Asia Pacific Synthetic Cannabinoids Market Attractiveness Analysis, By Distribution Channel, 2025 to 2035
Figure 60: Latin America Synthetic Cannabinoids Market Value (US$ Bn) Forecast, 2020 to 2035
Figure 61: Latin America Synthetic Cannabinoids Market Value Share Analysis, by Country/Sub-region, 2024 and 2035
Figure 62: Latin America Synthetic Cannabinoids Market Attractiveness Analysis, by Country/Sub-region, 2025 to 2035
Figure 63: Latin America Synthetic Cannabinoids Market Value Share Analysis, By Product Type, 2024 and 2035
Figure 64: Latin America Synthetic Cannabinoids Market Attractiveness Analysis, By Product Type, 2025 to 2035
Figure 65: Latin America Synthetic Cannabinoids Market Value Share Analysis, By Formulation, 2024 and 2035
Figure 66: Latin America Synthetic Cannabinoids Market Attractiveness Analysis, By Formulation, 2025 to 2035
Figure 67: Latin America Synthetic Cannabinoids Market Value Share Analysis, By Indication, 2024 and 2035
Figure 68: Latin America Synthetic Cannabinoids Market Attractiveness Analysis, By Indication, 2025 to 2035
Figure 69: Latin America Synthetic Cannabinoids Market Value Share Analysis, By Distribution Channel, 2024 and 2035
Figure 70: Latin America Synthetic Cannabinoids Market Attractiveness Analysis, By Distribution Channel, 2025 to 2035
Figure 71: Middle East & Africa Synthetic Cannabinoids Market Value (US$ Bn) Forecast, 2020 to 2035
Figure 72: Middle East & Africa Synthetic Cannabinoids Market Value Share Analysis, by Country/Sub-region, 2024 and 2035
Figure 73: Middle East & Africa Synthetic Cannabinoids Market Attractiveness Analysis, by Country/Sub-region, 2025 to 2035
Figure 74: Middle East & Africa Synthetic Cannabinoids Market Value Share Analysis, By Product Type, 2024 and 2035
Figure 75: Middle East & Africa Synthetic Cannabinoids Market Attractiveness Analysis, By Product Type, 2025 to 2035
Figure 76: Middle East & Africa Synthetic Cannabinoids Market Value Share Analysis, By Formulation, 2024 and 2035
Figure 77: Middle East & Africa Synthetic Cannabinoids Market Attractiveness Analysis, By Formulation, 2025 to 2035
Figure 78: Middle East & Africa Synthetic Cannabinoids Market Value Share Analysis, By Indication, 2024 and 2035
Figure 79: Middle East & Africa Synthetic Cannabinoids Market Attractiveness Analysis, By Indication, 2025 to 2035
Figure 80: Middle East & Africa Synthetic Cannabinoids Market Value Share Analysis, By Distribution Channel, 2024 and 2035
Figure 81: Middle East & Africa Synthetic Cannabinoids Market Attractiveness Analysis, By Distribution Channel, 2025 to 2035